The MedAustron Center for Ion Therapy has demonstrated the safety and efficacy of both, proton and carbon ion therapy for the treatment of skull based chordomas, a bone located cancer.
Aug 21 2023Reviewed by Lily Ramsey, LLM In a recent publication in Cancers the institution presented conclusive data from the treatment of 44 patients with this rare cancer. All patients were treated at MedAustron between August 2017 and October 2021 and received either proton or carbon ion therapy. The study shows that tumors with a volume below 49 cc could be extremely well controlled.
Efficacious & safe The analysis is based on 44 patients that received particle therapy at MedAustron between 2017 and 2021 and took part in a follow-up assessment of up to 55 months. Summarizing the results, Dr. Slavisa Tubin, Director of Clinical Radiobiology and Co-Scientific Director at MedAustron, comments: “Overall particle treatment achieved a local control of tumor growth of 95,5 % after two years and 90,9 % after three years.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Leicester: Work to begin on road where car crashed into houseA woman suffered a broken skull after the car crashed into her home in 2021.
Lire la suite »
Skull and Bones' next closed beta is next week, and there's no NDAUbisoft is running another closed beta for its upcoming swashbucklin' adventure, Skull and Bones. Setting sail at 3am U…
Lire la suite »
GMP grade cytokines for cell therapy and clinical applicationsSino Biological has the capability to produce GMP-grade cytokines which can play huge roles into cell therapy and clinical applications research.
Lire la suite »